VNR Biosciences

Hyderabad, India Founded: 2016 • Age: 10 yrs
Develops and manufactures API intermediates, pyridines, pyrimidines, and speciality chemicals services.

About VNR Biosciences

VNR Biosciences is a Chemicals & Materials company based in Hyderabad (India) founded in 2016 by Narsi Reddy Meda. It develops and manufactures API intermediates, pyridines, pyrimidines, and speciality chemicals services. It operates on a B2B and Service-based Contracts model. Its Indian entity Vnr Biosciences Private Limited reported revenue of β‚Ή1.14 Cr. VNR Biosciences offers products and services including Custom Synthesis, Process Chemistry, Chiral Synthesis, and API Intermediates. Its focus areas include Chemicals, Speciality Chemicals, API Intermediates and Pyridines and Pyrimidines. Similar companies include Sai Life Sciences, NFIL and Sapala Organics; 2 of its 3 listed similar companies have raised funding.

Company details

VNR BioSciences focuses on the development and manufacturing of chemical intermediates, including API intermediates, pyridines, and pyrimidines. They provide services such as custom synthesis, process chemistry, and chiral synthesis using advanced equipment and experienced scientists. Located in Hyderabad, India, they prioritize quality, safety, and timely delivery to serve various clients in the chemical industry. Their operations emphasize cost-optimized procedures while maintaining high standards.

  • Headquarters Hyderabad, India
  • Founders Narsi Reddy Meda
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website vnrbio.com
  • Legal Name Vnr Biosciences Private Limited
  • Date of Incorporation 15 Mar, 2016
  • Jurisdiction Secunderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹1.14 Cr

    FY 2025 · +142% YoY

  • Net Loss
    -₹25.3 Lakh

    FY 2025 · -22% margin

  • EBITDA
    -₹19.2 Lakh

    FY 2025 · -17% margin

Products & Services of VNR Biosciences

VNR Biosciences offers a comprehensive portfolio of products and services, including Custom Synthesis, Process Chemistry, Chiral Synthesis, and API Intermediates.

Custom Synthesis
Chemical Services

Service for tailored chemical synthesis processes.

Process Chemistry
Chemical Services

Development of efficient chemical processes for manufacturing.

Chiral Synthesis
Chemical Services

Synthesis of chiral compounds for specialized applications.

API Intermediates
Chemical Products

Intermediates used in active pharmaceutical ingredient production.

Board of directors of Vnr Biosciences Private Limited (VNR Biosciences)

Vnr Biosciences Private Limited is the primary company behind VNR Biosciences. The board of Vnr Biosciences Private Limited currently have 2 directors; the longest-serving is Narsi Reddy Meda, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Narsi Reddy Meda
DIN 07454815
Director15 Mar 201610 yrs 7 moVnr Biosciences Private Limited
Venkateshwar Reddy Chappeta
DIN 07454847
Director15 Mar 201610 yrs 7 moVnr Biosciences Private Limited

People of VNR Biosciences

1 people are tracked at VNR Biosciences (1 in leadership).

NameRoleGroup
Founder, DirectorLeadership
Premium access

Complete people profiles for VNR Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of VNR Biosciences

Figures of Vnr Biosciences Private Limited, the primary company behind VNR Biosciences, for FY 2025. Revenue was ₹1.14 Cr (+142% year on year). Net loss was -₹25.3 Lakh (-22% margin). EBITDA was -₹19.2 Lakh (-17% margin). Revenue has grown at a compounded annual rate of -32% over three years and -1% over five years.

  • ₹1.14 CrRevenue · FY 2025 · +142% YoY
  • -₹25.3 LakhNet loss · -22% margin
  • -₹19.2 LakhEBITDA · -17% margin
  • ₹1.5 LakhPaid-up capital
  • -32%Revenue CAGR, 3 years
  • -1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Vnr Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for VNR Biosciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to VNR Biosciences

VNR Biosciences has 3 listed similar companies in our database, 2 of them funded. They include Sai Life Sciences, NFIL and Sapala Organics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sailife.com1999Hyderabad, India$112.18M2,948
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
nfil.in1967Mumbai, India1,476
Fluorinated compounds are synthesized and manufactured customly for various industries.
sapalaorganics.com2005Hyderabad, India$734,962219
Research organization specializing in custom synthesis of various organic compounds
Premium access

Detailed similar companies of VNR Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Petrochemicals & Derivatives

3 companies that operate in the same segment as VNR Biosciences (Petrochemicals & Derivatives) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Produces and supplies specialty chemicals for energy, petrochemicals, and industrial applications worldwide.
1992Mumbai, Maharashtra, IndiaUSD 479.49 M976
Polybutene-based petrochemicals are produced by the company.
1990Chennai, Tamil Nadu, IndiaUSD 62.67 M194
Calcined petroleum coke, coal tar, and specialty chemicals are produced.
1974Hyderabad, Telangana, IndiaUSD 1.88 B2,390
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about VNR Biosciences

VNR Biosciences was founded in 2016.

VNR Biosciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind VNR Biosciences, Vnr Biosciences Private Limited, reported revenue of β‚Ή1.14 Cr for FY 2025, up 142% year on year.

VNR BioSciences focuses on the development and manufacturing of chemical intermediates, including API intermediates, pyridines, and pyrimidines. They provide services such as custom synthesis, process chemistry, and chiral synthesis using advanced equipment and experienced scientists. Located in Hyderabad, India, they prioritize quality, safety, and timely delivery to serve various clients in the chemical industry. Their operations emphasize cost-optimized procedures while maintaining high standards.

VNR Biosciences's top competitors include Sai Life Sciences, NFIL and Sapala Organics.

VNR Biosciences offers Custom Synthesis, Process Chemistry, Chiral Synthesis, and API Intermediates.

VNR Biosciences operates through Vnr Biosciences Private Limited.

The legal entities of VNR Biosciences currently have 2 directors, including Narsi Reddy Meda, Venkateshwar Reddy Chappeta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available